Category Archives: Rare/Orphan Disease

Edenbridge Pharmaceuticals Selects Specialty Pharmacies to Distribute Yargesa

Edenbridge Pharmaceuticals Selects PANTHERx Rare and Orsini Specialty Pharmacy to Distribute Yargesa to Treat Gaucher Disease

Pyros Pharmaceuticals Selects Anovo as Exclusive Specialty Pharmacy For VIGPODER

Pyros Pharmaceuticals Selects Anovo as Exclusive Distributor and Specialty Pharmacy For VIGPODER to Treat Infantile Spasms

Specialty Pharmacy News Roundup: December 2023

The following company announcements are just a few of the specialty pharmacy company activities from this month. Subscribe to AMI’s Specialty Pharmacy Database to stay up to date on company and industry trends

PANTHERx Selected by UCB as Exclusive Specialty Pharmacy for ZILBRYSQ

Zilbrysq is available through the specialty pharmacy PANTHERx Rare Pharmacy and through a Risk Evaluation and Mitigation Strategy (REMS) program because of the risk of serious meningococcal infections.

Independence Blue Cross and Sun Life Collaborate on Stop Loss Insurance

Independence Blue Cross and Sun Life U.S. collaborate to provide Stop Loss insurance for Independence’s self-funded group customers

Employer Plans View Product Coverage Very Differently from PBMs

Employers’ benefit coverage decisions and the impact those decisions have on the market for rare disease / orphan drugs are a growing concern for biopharma companies

Independence Blue Cross Launches Gene Therapeutics Network

BlueCross Blue Shield Plans: Access Market Intelligence

Independence Blue Cross (Independence) recently announced the launch of its Advanced Network for Gene-Based Therapeutics, which will be effective March 1, 2023

Specialty Pharmacy Limited Distribution Drug Agreements at Year-End 2022

The leading specialty pharmacies were busy signing limited distribution drug agreements at the end of 2022. Here’s a round-up of the activities